ecancer

Editor's Choice for March 2016

Prof Gordon McVie - ecancer Editor

31 Mar 2016

Editor's choice for January 2016

Prof Gordon McVie - ecancer Editor

2 Feb 2016

What does the iManageCancer project hope to achieve?

Prof Gordon McVie - ecancer Managing Editor

23 Dec 2015

Editor's choice for December 2015

Prof Gordon McVie - ecancer Editor

16 Dec 2015

Results from the cancer registry of the National Oncology Centre of Luanda, Angola

Dr António Armando -National Oncology Centre of Luanda, Luanda, Angola

8 Dec 2015

ASH 2015: Latest in CLL

Prof John Gribben, Prof Stephan Stilgenbauer, Dr Alessandra Tedeschi, Dr Patrick Thornton

7 Dec 2015

Long-term outcomes after blinatumomab treatment for ALL

Dr Nicola Gökbuget - University of Frankfurt, Frankfurt, Germany

7 Dec 2015

ASH 2015: Highlights

ecancertv

7 Dec 2015

How is cancer-related venous thromboembolism treated in real world practice?

Prof Alok Khorana - Cleveland Clinic, Cleveland, USA

7 Dec 2015

Dalteparin thromboprophylaxis for cancer patients at high risk of venous thromboembolism

Prof Alok Khorana - Cleveland Clinic, Cleveland, USA

7 Dec 2015

Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder

Prof Corrado Tarella - Istituto Europeo di Oncologia, Milano, Italy

7 Dec 2015

“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer treatment

Dr Sudipto Mukherjee - Cleveland Clinic, Cleveland, USA

7 Dec 2015

More from ecancer